Current and potential therapeutic options for infections caused by difficult-to-treat and pandrug resistant gram-negative bacteria in critically ill patients

H Giamarellou, I Karaiskos - Antibiotics, 2022 - mdpi.com
Carbapenem resistance in Gram-negative bacteria has come into sight as a serious global
threat. Carbapenem-resistant Gram-negative pathogens and their main representatives …

The Challenge of overcoming antibiotic resistance in carbapenem-resistant Gram-negative bacteria:“Attack on Titan”

G Mancuso, S De Gaetano, A Midiri, S Zummo… - Microorganisms, 2023 - mdpi.com
The global burden of bacterial resistance remains one of the most serious public health
concerns. Infections caused by multidrug-resistant (MDR) bacteria in critically ill patients …

Epidemiology, mechanisms of resistance and treatment algorithm for infections due to carbapenem-resistant gram-negative bacteria: an expert panel opinion

N Coppola, AE Maraolo, L Onorato, R Scotto, F Calò… - Antibiotics, 2022 - mdpi.com
Antimicrobial resistance represents a serious threat for global health, causing an
unacceptable burden in terms of morbidity, mortality and healthcare costs. In particular, in …

Antimicrobial resistance in the intensive care unit: a focus on gram-negative bacterial infections

SH MacVane - Journal of intensive care medicine, 2017 - journals.sagepub.com
Bacterial infections are a frequent cause of hospitalization, and nosocomial infections are an
increasingly common condition, particularly within the acute/critical care setting. Infection …

Rationale and evidence for the use of new beta-lactam/beta-lactamase inhibitor combinations and cefiderocol in critically ill patients

F Barbier, S Hraiech, S Kernéis, N Veluppillai… - Annals of Intensive …, 2023 - Springer
Background Healthcare-associated infections involving Gram-negative bacteria (GNB) with
difficult-to-treat resistance (DTR) phenotype are associated with impaired patient-centered …

Antibiotic therapy strategies for treating gram-negative severe infections in the critically Ill: A narrative review

A Corona, V De Santis, A Agarossi, A Prete… - Antibiotics, 2023 - mdpi.com
Introduction: Not enough data exist to inform the optimal duration and type of antimicrobial
therapy against GN infections in critically ill patients. Methods: Narrative review based on a …

Antimicrobial treatment challenges in the era of carbapenem resistance

AM Peri, Y Doi, BA Potoski, PNA Harris… - … and infectious disease, 2019 - Elsevier
Infections due to carbapenem-resistant Gram-negative bacteria are burdened by high
mortality and represent an urgent threat to address. Clinicians are currently at a dawn of a …

Resistant gram-negative infections

H Fraimow, R Nahra - Critical care clinics, 2013 - criticalcare.theclinics.com
Resistant Gram-Negative Infections - Critical Care Clinics Skip to Main Content Advertisement
Critical Care Clinics Log in Register Log in Subscribe Claim Skip menu theclinics.com …

Global threat of carbapenem-resistant gram-negative bacteria

SS Jean, D Harnod, PR Hsueh - Frontiers in cellular and infection …, 2022 - frontiersin.org
Infections caused by multidrug-resistant (MDR) and extensively drug-resistant (XDR) Gram-
negative bacteria (GNB), including carbapenem-resistant (CR) Enterobacterales (CRE; …

Treatment for infections with carbapenem-resistant Enterobacteriaceae: what options do we still have?

M Yamamoto, AE Pop-Vicas - Critical Care, 2014 - Springer
The global spread of carbapenem-resistant Enterobacteriaceae (CRE) is increasingly
becoming a major challenge in clinical and public health settings. To date, the treatment for …